Self/non-self discrimination by human γδ T cells: simple solutions for a complex issue

• Published in: Immunological reviews Vol. 215; no. 1; pp. 123 - 135
• Main Authors: Thedrez, Aurélie, Sabourin, Caroline, Gertner, Julie, Devilder, Marie-Claire, Allain-Maillet, Sophie, Fournié, Jean-Jacques, Scotet, Emmanuel, Bonneville, Marc
• Format: Journal Article
• Language: English
• Published: Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.02.2007; Blackwell Publishing Ltd; Wiley
• Subjects: Cellular Biology; immunity; immunotherapy; innate immunity; Life Sciences; T lymphocyte; T-cell receptor
• ISSN: 0105-2896; 1600-065X
• DOI: 10.1111/j.1600-065X.2006.00468.x

Although γδ T cells express clonally distributed T-cell receptors (TCRs), a hallmark of adaptive immunity, they are classically considered as innate-like effectors, owing to the high frequency of preactivated γδ T cells, with restricted antigen recognition repertoire in particular tissue locations. Actually, such features are shared only by a fraction of γδ T-cell subsets located in the skin and reproductive organ mucosa in rodents or in peripheral blood in humans. By contrast, other γδ subsets, e.g. those found in rodent and human spleen, show diverse antigenic reactivity patterns and mixed naive/memory phenotypes. Thus, γδ T cells are made of both 'primitive' subsets endowed with innate-like properties and 'evolved' subsets able to mount anamnestic responses like conventional major histocompatibility complex-restricted αβ T cells. In this article, we show that human γδ T cells, although heterogeneous, do share recurrent innate features that distinguish them from mainstream αβ T cells. In particular, most of them are activated on TCR- or natural killer receptor-mediated recognition of a restricted set of conserved yet poorly defined endogenous stress determinants. This rather simple recognition mechanism allows human γδ T cells to discriminate healthy cells from altered cells and to exert a variety of immunostimulatory or regulatory functions. The recent availability of synthetic γδ T-cell agonists mimicking these natural stress-induced ligands have fostered development of immunotherapeutic strategies, with broad indications against infectious and tumor diseases, which are briefly reviewed here.